Results 131 to 140 of about 12,006,097 (356)

Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter? [PDF]

open access: yes, 2007
INTRODUCTION: The aim of this study was to investigate the utilization of breast, colon and prostate cancer screening in the adult Croatian population in a period without national cancer screening programs, with a special interest in respondents' rural ...
Kern, Josipa   +5 more
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials [PDF]

open access: bronze, 2019
Ann Lin   +12 more
openalex   +1 more source

An Evaluation of the Impact of Weston Park Cancer Support Centre [PDF]

open access: yes, 2020
Dayson, Christopher   +2 more
core   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Life, death, and autophagy in cancer: NF-κB turns up everywhere [PDF]

open access: gold, 2020
Daniela Verzella   +7 more
openalex   +1 more source

Goodman Cancer Institute Research Symposium

open access: yesMcGill Journal of Medicine, 2022
Goodman Cancer Institute
doaj   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer [PDF]

open access: bronze, 2015
Jeanne Tie   +17 more
openalex   +1 more source

Home - About - Disclaimer - Privacy